Atlas Trials

Specific Molecular Imaging of DX600 Labeled by PET Radionuclide Targeting ACE2 in Patients

Clinical trial NCT04422457 · COMPLETED

Trial details

NCT number
NCT04422457
Sponsor
Peking University Cancer Hospital & Institute
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Solid Tumor
Start date
2020-06-13
Primary completion
2022-03-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.